AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2024
Mar 12, 2024
30786_dirs_2024-03-12_7e28a7d0-e8a2-478b-9f58-81e1f67861b4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-RAD LABORATORIES, INC. (BIO BIOB)
CIK: 0000012208
Period of Report: 2024-03-08
Reporting Person: Last Andrew J. (EVP, Chief Operating Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-03-08 | Non-Qualified Stock Option (right to buy) | $343.76 | A | 5891 | Acquired | 2034-03-08 | Bio-Rad A Common Stock (5891) | Direct |
Footnotes
F1: The stock option vests over four years at 25% per year on the yearly anniversary date of the grant.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Earnings Release
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13